Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions.

25-Hydroxyvitamin D2 25-Hydroxyvitamin D3 Ligand binding assay Liquid chromatography–tandem mass spectrometry (LC–MS/MS) Total 25-hydroxyvitamin D Vitamin D External Quality Assessment Scheme (DEQAS)

Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 23 08 2021
accepted: 18 10 2021
revised: 12 10 2021
pubmed: 10 11 2021
medline: 24 2 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

The Vitamin D External Quality Assessment Scheme (DEQAS) distributes human serum samples four times per year to over 1000 participants worldwide for the determination of total serum 25-hydroxyvitamin D [25(OH)D)]. These samples are stored at -40 °C prior to distribution and the participants are instructed to store the samples frozen at -20 °C or lower after receipt; however, the samples are shipped to participants at ambient conditions (i.e., no temperature control). To address the question of whether shipment at ambient conditions is sufficient for reliable performance of various 25(OH)D assays, the equivalence of DEQAS human serum samples shipped under frozen and ambient conditions was assessed. As part of a Vitamin D Standardization Program (VDSP) commutability study, two sets of the same nine DEQAS samples were shipped to participants at ambient temperature and frozen on dry ice. Twenty-eight laboratories participated in this study and provided 34 sets of results for the measurement of 25(OH)D using 20 ligand binding assays and 14 liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. Equivalence of the assay response for the frozen versus ambient DEQAS samples for each assay was evaluated using multi-level modeling, paired t-tests including a false discovery rate (FDR) approach, and ordinary least squares linear regression analysis of frozen versus ambient results. Using the paired t-test and confirmed by FDR testing, differences in the results for the ambient and frozen samples were found to be statistically significant at p < 0.05 for four assays (DiaSorin, DIAsource, Siemens, and SNIBE prototype). For all 14 LC-MS/MS assays, the differences in the results for the ambient- and frozen-shipped samples were not found to be significant at p < 0.05 indicating that these analytes were stable during shipment at ambient conditions. Even though assay results have been shown to vary considerably among different 25(OH)D assays in other studies, the results of this study also indicate that sample handling/transport conditions may influence 25(OH)D assay response for several assays.

Identifiants

pubmed: 34750644
doi: 10.1007/s00216-021-03742-5
pii: 10.1007/s00216-021-03742-5
doi:

Substances chimiques

Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1015-1028

Informations de copyright

© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Références

Carter GD, Berry J, Durazo-Arvizu R, Gunter E, Jones G, Jones J, et al. Hydroxyvitamin D assays: an historical perspective from DEQAS. J Steroid Biochem Mol Biol. 2018;177:30–5. https://doi.org/10.1016/j.jsbmb.2017.07.018 .
doi: 10.1016/j.jsbmb.2017.07.018 pubmed: 28734989 pmcid: 28734989
Burdette CQ, Camara JE, Nalin F, Pritchett J, Sander LC, Carter GD, et al. Establishing an accuracy basis for the Vitamin D External Quality Assessment Scheme (DEQAS). J AOAC Int. 2017;100(5):1277–87. https://doi.org/10.5740/jaoacint.17-0306 .
doi: 10.5740/jaoacint.17-0306 pubmed: 28847346
Tai SSC, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D
doi: 10.1021/ac9026862 pubmed: 20136128 pmcid: 2838390
Mineva EM, Schleicher RL, Chaudhary-Webb M, Maw KL, Botelho JC, Vesper HW, et al. A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D-3 and 25-hydroxyvitamin D-2 using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2015;407(19):5615–24. https://doi.org/10.1007/s00216-015-8733-z .
doi: 10.1007/s00216-015-8733-z pubmed: 25967149 pmcid: 4823009
Erdman P, Palmer-Toy DE, Horowitz G, Hoofnagle A. Accuracy-based vitamin D survey six years of quality improvement guided by proficiency testing. Arch Pathol Lab Med. 2019;143(12):1531–8. https://doi.org/10.5858/arpa.2018-0625-CP .
doi: 10.5858/arpa.2018-0625-CP pubmed: 31116045
Hoofnagle A. Personal Communication. 2020.
College of American Pathologists (CAP).  https://elss.cap.org/elss/ShowProperty?nodePath=/UCMCON/Contribution%20Folders/WebApplications/pdf/istore-shipping.pdf . Accessed 11/2/2021.
Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM, VDSP. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest. 2012;72:32–40. https://doi.org/10.3109/00365513.2012.681935 .
doi: 10.3109/00365513.2012.681935
Wise SA, Tai SSC, Burdette CQ, Camara JE, Bedner M, Lippa KA, et al. Role of the National Institute of Standards and Technology (NIST) in support of the vitamin D initiative of the National Institutes of Health, Office of Dietary Supplements. J AOAC Int. 2017;100(5):1260–76. https://doi.org/10.5740/jaoacint.17-0305 .
doi: 10.5740/jaoacint.17-0305 pubmed: 28863788
Camara JE, Wise SA, Hoofnagle AN, Williams EL, Carter GD, Jones J, et al. Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2. Anal Bioanal Chem. 2021;413:5067–84. https://doi.org/10.1007/s00216-021-03470-w .
doi: 10.1007/s00216-021-03470-w pubmed: 34184102
Wise SA, Camara JE, Sempos CT, Burdette CQ, Hahm G, Nalin F, et al. Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) intercomparison study 2 – Part 1 Liquid chromatography – tandem mass spectrometry (LC-MS/MS) assays – Impact of 3-epi-25-hydroxyvitamin D
Wise SA, Camara JE, Sempos CT, Burdette CQ, Hahm G, Nalin F, et al. Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) intercomparison study 2 - part 2 ligand binding assays – impact of 25-hydroxyvitamin D
Wise SA, Camara JE, Sempos CT, Lukas P, Le Goff C, Peeters S, et al. Vitamin D Standardization Program (VDSP) Intralaboratory study for the assessment of 25-hydroxyvitamin D assay performance. J Steroid Biochem Mol Biol. 2021;212:105917. https://doi.org/10.1016/j.jsbmb.2021.105917 .
doi: 10.1016/j.jsbmb.2021.105917 pubmed: 34010687
Tai SSC, Nelson MA. Candidate reference measurement procedure for the determination of (24R),25-dihydroxyvitamin D
doi: 10.1021/acs.analchem.5b01861 pubmed: 26171884
Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. Volume I: Continuous Responses: Strata Press; 2012.
Snijders TAB, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. 2nd ed: Sage Publications Ltd.; 2012.
Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Royal Stat Soc Series B-Stat Methodol. 1995;57(1):289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x .
doi: 10.1111/j.2517-6161.1995.tb02031.x
Rosner B. Fundamentals of biostatistics. 8th ed: Cengage Learning; 2016.

Auteurs

Christopher T Sempos (CT)

Office of Dietary Supplements (ODS), National Institutes of Health (NIH), Bethesda, MD, 20892, USA.
Vitamin D Standardization Program LLC, Havre de Grace, MD, 21078, USA.

Emma L Williams (EL)

Imperial Healthcare NHS Trust, London, W6 8RF, UK.

Graham D Carter (GD)

Imperial Healthcare NHS Trust, London, W6 8RF, UK.

Julia Jones (J)

Imperial Healthcare NHS Trust, London, W6 8RF, UK.

Johanna E Camara (JE)

Chemical Sciences Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA.

Carolyn Q Burdette (CQ)

Chemical Sciences Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA.

Grace Hahm (G)

Chemical Sciences Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA.

Federica Nalin (F)

Chemical Sciences Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA.

David L Duewer (DL)

Chemical Sciences Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA.

Adam J Kuszak (AJ)

Office of Dietary Supplements (ODS), National Institutes of Health (NIH), Bethesda, MD, 20892, USA.

Joyce Merkel (J)

Office of Dietary Supplements (ODS), National Institutes of Health (NIH), Bethesda, MD, 20892, USA.

Andrew N Hoofnagle (AN)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98185, USA.

Pierre Lukas (P)

Clinical Chemistry, University of Liège, CHU de Liège, 4000, Liège, Belgium.

Étienne Cavalier (É)

Clinical Chemistry, University of Liège, CHU de Liège, 4000, Liège, Belgium.

Ramón A Durazo-Arvizu (RA)

Biostatistics Core, The Sabin Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90027, USA.

Peter M Crump (PM)

Computing and Biometry, University of Wisconsin-Madison, Madison, WI, 53706, USA.

Christian Popp (C)

Abbott Laboratories, ADD Wiesbaden Abbott GmbH, 65205, Wiesbaden, Germany.

Christian Beckert (C)

Abbott Laboratories, ADD Wiesbaden Abbott GmbH, 65205, Wiesbaden, Germany.

Jan Schultess (J)

Abbott Laboratories, ADD Wiesbaden Abbott GmbH, 65205, Wiesbaden, Germany.

Glen Van Slooten (G)

Awareness Technology, Inc., Palm City, FL, 34990, USA.

Carole Tourneur (C)

bioMérieux, 69280, Marcey-l'Étoile, France.

Camille Pease (C)

bioMérieux, 69280, Marcey-l'Étoile, France.

Ravi Kaul (R)

Bio-Rad Laboratories, Clinical Diagnostics, Hercules, CA, 94547, USA.

Alfredo Villarreal (A)

Bio-Rad Laboratories, Clinical Diagnostics, Hercules, CA, 94547, USA.

Fiona Ivison (F)

Central Manchester Foundation Trust, Manchester, M13 9WL, UK.

Ralf Fischer (R)

Chromsystems Instruments & Chemicals GmbH, 82166, Gräfelfing, Germany.

Jody M W van den Ouweland (JMW)

Canisius Wilhelmina Hospital (CWZ), 6532 SZ, Nijmegen, The Netherlands.

Chung S Ho (CS)

Biochemical Mass Spectrometry Unit, Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, 999077.

Emmett W K Law (EWK)

Biochemical Mass Spectrometry Unit, Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, 999077.

Jean-Nicolas Simard (JN)

Endoceutics, Québec, G1P 4P5, Canada.

Renaud Gonthier (R)

Endoceutics, Québec, G1P 4P5, Canada.

Brett Holmquist (B)

Endocrine Sciences, LabCorp Specialty Testing Group, Agoura Hills, CA, 91301, USA.

Marcelo Cidade Batista (MC)

Clinical Lab, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil.

Sarah Meadows (S)

Medical Research Council (MRC) Elsie Widdowson Laboratory (Closed Dec. 2018), Cambridge, CB2 0SL, UK.
NIHR BRC Nutritional Biomarker Laboratory, MRC Epidemiology Unit, University of Cambridge, Cambridge, CB2 0SL, UK.

Lorna Cox (L)

Medical Research Council (MRC) Elsie Widdowson Laboratory (Closed Dec. 2018), Cambridge, CB2 0SL, UK.
NIHR BRC Nutritional Biomarker Laboratory, MRC Epidemiology Unit, University of Cambridge, Cambridge, CB2 0SL, UK.

Eugene Jansen (E)

National Institute of Public Health and the Environment (RIVM), 3720 BA, Bilthoven, The Netherlands.

Dilshad Ahmed Khan (DA)

National University of Medical Sciences (NUMS), Rawalpindi, 46000, Punjab, Pakistan.

Kimberly Robyak (K)

College of Medicine, Penn State University, Hershey, PA, 17033, USA.

Michael H Creer (MH)

College of Medicine, Penn State University, Hershey, PA, 17033, USA.

Mark Kilbane (M)

Clinical Chemistry, St. Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4, Ireland.

Patrick J Twomey (PJ)

Clinical Chemistry, St. Vincent's University Hospital, Elm Park, Dublin 4, D04 T6F4, Ireland.

James Freeman (J)

Siemens-Healthineers, Tarrytown, NY, 10591, USA.

Neil Parker (N)

Siemens-Healthineers, Tarrytown, NY, 10591, USA.

Jinyun Yuan (J)

SNIBE, Shenzhen, 518122, People's Republic of China.

Robert Fitzgerald (R)

Health Clinical Laboratories, University of California at San Diego, La Jolla, CA, 92093, USA.

Sohail Mushtaq (S)

University of Chester, Chester, CH1 4BJ, UK.

Michael W Clarke (MW)

Metabolomics Australia, Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, Perth, WA, 6009, Australia.

Norma Breen (N)

Waters Technologies Ireland Ltd., Wexford, Y35 D431, Ireland.

Christine Simpson (C)

School of Medicine, Yale University, New Haven, CT, 06510, USA.

Stephen A Wise (SA)

Office of Dietary Supplements (ODS), National Institutes of Health (NIH), Bethesda, MD, 20892, USA. Stephen.wise@nih.gov.
Scientist Emeritus, National Institute of Standards and Technology (NIST), Gaithersburg, MD, 20899, USA. Stephen.wise@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH